Skip to main content

Displaying 1177 - 1188 of 2277

Insiders Are Hot for This Summer Rally

August 4, 2022

Insiders are finally buying into the summer rally. We haven’t seen this much action on our Hot List in months!

The largest insider transaction on today’s list is a Form 4 filing by the Chairman and CEO of American Assets Trust $AAT, with a roughly $1 million purchase.

All Star Charts Premium, 2 to 100 Club

2 to 100 Club (08-03-2022)

August 3, 2022

From the desk of Steve Strazza @Sstrazza

Welcome to the 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach. It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

August Strategy Session: 3 Key Takeaways

August 3, 2022

From the Desk of Steve Strazza @Sstrazza

We held our August Monthly Strategy Session Monday night. Premium Members can access and re-watch it here.

Non-members can get a quick recap of the call simply by reading this post each month.

By focusing on long-term, monthly charts, the idea is to take a step back and put things into the context of their structural trends.

This is easily one of our most valuable exercises as it forces us to put aside the day-to-day noise and simply examine markets from a “big-picture” point of view.

With that as our backdrop, let’s dive right in and discuss three of the most important charts and/or themes from this month’s call.

Insiders Are Buying LXRX

August 2, 2022

The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.

Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.

All Star Charts Premium

The Minor Leaguers (08-01-2022)

August 1, 2022

From the desk of Steve Strazza @Sstrazza

Welcome to our latest Minor Leaguers report.

We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.

All Star Charts Premium

Follow the Flow (08-01-2022)

August 1, 2022

From the desk of Steve Strazza @sstrazza

This is one of our favorite bottom-up scans: Follow the Flow.

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

[PLUS] Weekly Top 10 Report

August 1, 2022

From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we're currently seeing in asset classes around the world.

Real Yields Roll in Favor of Gold

There has been plenty of evidence suggesting a significant breakdown in one of the world’s most critical inflationary assets, Gold. Miners look terrible, Silver and Platinum are weak, and the Silver/Gold ratio recently hit multi-year lows. These aren’t the type of data points that support higher gold prices. Real yields are another piece of evidence we can add to that list. The chart below shows the US 10-year real rate inverted and a chart of Gold. They look almost identical. Gold futures tend to trend lower when real rates rise (moving lower on the chart). Despite every reason to break down, Gold has remained resilient. And now, as many of the negative data points mentioned above begin to reverse, including real yields, a rally in gold could ensue. 

[PLUS] Weekly Momentum Report & Takeaways

August 1, 2022

From the desk of Steve Strazza @Sstrazza

Check out this week's Momentum Report, our weekly summation of all the major indexes at a Macro, International, Sector, and Industry Group level.

By analyzing the short-term data in these reports, we get a more tactical view of the current state of markets. This information then helps us put near-term developments into the big picture context and provides insights regarding the structural trends at play.

Let's jump right into it with some of the major takeaways from this week's report:

* ASC Plus Members can access the Momentum Report by clicking the link at the bottom of this post.

Macro Universe:

Options Flow Is Split on Semiconductors

August 1, 2022

CD&R Investment Associates disclosed the purchase of approximately $6 million worth of Beacon Roofing Supply $BECN in a Form 4 on Friday.

The firm now owns 24,348,048 shares, which represents a roughly 35% ownership stake in the mid-cap building products company.

All Star Charts Premium

The Hall of Famers (07-29-2022)

July 29, 2022

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list: